Pharmacogenetics of chronic obstructive pulmonary disease: challenges and opportunities.
Pharmacogenetics of chronic obstructive pulmonary disease: challenges and opportunities.
复制标题
DOI:
10.2217/pgs.09.176
复制
发表时间:
2010-02
期刊:
影响因子:
2.1
通讯作者:
Hersh CP
中科院分区:
文献类型:
--
作者:
Hersh CP
Similar to other common chronic diseases, chronic obstructive pulmonary disease (COPD) is a heterogeneous disorder with multiple disease subtypes. Candidate gene studies have found genetic associations for COPD-related phenotypes that may be relevant for pharmacogenetics studies, including lung function decline and COPD exacerbations. However, few COPD pharmacogenetics studies have been completed. Most studies have focused on the role of variants in the β2-adrenergic receptor gene on bronchodilator response, but the findings have been inconclusive. Candidate gene studies highlight the concept that genes for COPD susceptibility may also be relevant in COPD pharmacogenetics. Currently, there are no clinical applications of pharmacogenetics to COPD therapy, but the use of pharmacogenetics to determine initial smoking cessation therapy may be closer to clinical application.
登录
查看更多内容
影响因子:
3.7
作者:
Caporaso N;Gu F;Chatterjee N;Sheng-Chih J;Yu K;Yeager M;Chen C;Jacobs K;Wheeler W;Landi MT;Ziegler RG;Hunter DJ;Chanock S;Hankinson S;Kraft P;Bergen AW
通讯作者:
Bergen AW
DOI:
10.1164/rccm.200903-0488oc
发表时间:
2009-09-15
影响因子:
24.7
作者:
Dransfield, Mark T.;Nahm, Moon H.;Bailey, William C.
通讯作者:
Bailey, William C.
影响因子:
9.6
作者:
Drummond, Michael B.;Blackford, Amanda L.;Wise, Robert A.
通讯作者:
Wise, Robert A.
影响因子:
8.9
作者:
Christie, Jason D.;Edwards, Leah B.;Hertz, Marshall I.
通讯作者:
Hertz, Marshall I.
DOI:
10.1164/ajrccm.154.4.8887592
发表时间:
1996-10-01
影响因子:
24.7
作者:
Connors, AF;Dawson, NV;Knaus, WA
通讯作者:
Knaus, WA